Table 2.
Stages | A β (PET or CSF) | Neuronal injury markers (FDG, tau, MRI) | Subtle cognitive change |
---|---|---|---|
Stage 1 (Asymptomatic cerebral amyloidosis) | Positive | Negative | Negative |
Stage 2 (Amyloid positivity + synaptic dysfunction and/or neurodegeneration) | Positive | Positive | Negative |
Stage 3 (Amyloid positivity + neurodegeneration + subtle cognitive decline) | Positive | Positive | Positive |